MRI of the Spine with Contrast is the Imaging Modality of Choice for Transverse Myelitis
MRI of the spine is the reference standard for diagnosing transverse myelitis, with contrast-enhanced imaging recommended for initial diagnostic evaluation 1. This modality provides superior soft-tissue resolution and multiplanar capability, making it ideal for visualizing spinal cord pathology while simultaneously excluding alternative etiologies.
Why MRI is Superior
MRI excels in evaluating transverse myelitis because it:
- Directly visualizes the spinal cord and inflammatory changes that characterize demyelinating diseases 1
- Detects lesion patterns that help distinguish between different causes of myelopathy (e.g., longitudinally extensive lesions in neuromyelitis optica versus short ovoid lesions in multiple sclerosis) 2
- Provides both anatomical and pathological information about the osseous spinal column and spinal cord noninvasively 1
- Identifies enhancement patterns that suggest inflammatory versus infectious versus other etiologies 1
Specific MRI Protocol Recommendations
Contrast administration is essential for initial evaluation 1. The ACR Appropriateness Criteria explicitly state that contrast-enhanced imaging is recommended for initial diagnostic evaluation of suspected demyelinating disease 1. This helps:
- Characterize the inflammatory process
- Exclude alternative diagnoses like infection or tumor
- Assess blood-cord barrier breakdown
- Guide prognosis and treatment decisions
Coverage Areas
Image the cervical, thoracic, and lumbar spine comprehensively 1. Transverse myelitis most commonly affects the cervical cord, but thoracic involvement is also frequent, necessitating complete spinal imaging to assess the full extent of disease.
Advanced Sequences to Consider
Diffusion-weighted imaging should be included when there is concern for spinal cord ischemia as a differential diagnosis, as it can show signal alteration earlier than T2-weighted sequences 1. This helps distinguish vascular from inflammatory etiologies.
Alternative Modalities Are Inadequate
The guidelines are clear that other imaging modalities have no role in initial evaluation:
- CT spine: Only useful for bony pathology, provides poor visualization of the spinal cord itself 1
- CT myelography: May answer specific pre-surgical questions but is not appropriate for initial inflammatory workup 1
- Radiographs: Cannot visualize the spinal cord and have no role in transverse myelitis diagnosis 1
- MRA/CTA: No relevant literature supports their use in initial evaluation of acute myelopathy 1
Critical Clinical Caveat: MRI-Negative Cases
Approximately 10-40% of transverse myelitis cases may have normal initial MRI 3, 4. In these scenarios:
- Do not exclude the diagnosis based on negative imaging alone
- Proceed with cerebrospinal fluid analysis (elevated gamma globulins, myelin basic protein, oligoclonal bands) 5, 4
- Consider repeat MRI in 2-7 days, as lesions may become apparent with time 6
- Clinical examination showing upper motor neuron signs with sensory level remains diagnostic even without imaging confirmation 4
The 2024 case report emphasizes that despite MRI being the critical diagnostic tool, clinical judgment must prevail when imaging is negative but clinical suspicion remains high 7, 4.
Prognostic Value
MRI findings also provide prognostic information. Longitudinally extensive lesions (≥3 vertebral segments) suggest neuromyelitis optica spectrum disorder and warrant specific antibody testing (AQP4-IgG, MOG-IgG) 6, 8. The pattern and extent of cord involvement on initial MRI correlate with long-term disability outcomes 6.